¥È¥Ã¥×
|
²ñ¼Ò³µÍ×
|
¶È̳ÈÏ°Ï
|
ÆÈÆäÊËÝÌõÉô
|
ÉʼÁÊݾÚ
|
À®¸ùÎã
|
ºÎÍѾðÊó
|
¤ªÌ䤤¹ç¤ï¤»
¶È̳ÈÏ°Ï
 
´ðÁðå³Ø¤ÈÎ×¾² ¾Ü¤·¤¯

À¸Íý³Ø¡¢ÉÂÍý³Ø¡¢À¸Êª²½³Ø¡¢Ê¬»ÒÀ¸Êª³Ø¡¢¥Ð¥¤¥ª°å³Ø¹©Äø¡¢½Û´Ä´ïÆâ²Ê¡¢¸ÆµÛ´ïÆâ²Ê¡¢Ç¾³°²Ê¡¢¿À·Ð³°²Ê...

 
Ìô³Ø»ñÎÁ ¾Ü¤·¤¯

ÌôÍý³Ø¡¢ÆÇÍý³Ø¡¢ÌôÉʲ½³Ø¡¢ÌôÉÊʬÀϳء¢ÌôºÞ³Ø¡¢À½ºÞ½èÊý¤ª¤è¤Óµ»½Ñ¡¢¸¶ÎÁ¡¦ÊäºÞ¤ÎͳÍ褪¤è¤ÓÉʼÁ´ð...

 
°åÎÅ´ï³£¤ª¤è¤ÓÀ½ÉÊ ¾Ü¤·¤¯

IEC¡Ê¹ñºÝÅŵ¤É¸½à²ñµÄ¡ËÊó¹ð¡¢¥ì¥ó¥È¥²¥óµ¡´ï¡¢Ä¶²»Çȵ¡´ï¡¢MRI¡¢CT¡¢¸ÆµÛµ¡¡¢·ì±Õ¾ô²½Íѵ¡...

 
¹ñºÝ²ñµÄƱ»þÄÌÌõ ¾Ü¤·¤¯

¹ñºÝ²ñµÄ¡¢¸¦µæƤÏÀ²ñ¡¢Ç¯²ñ²ñµÄ¤Î¸½¾ìÄÌÌõ¡¢Æ±»þÄÌÌõ¡¢±óµ÷Î¥²ñµÄËÝÌõ¡¢±ÇÁü»ñÎÁ¡¢Âç²ñµÄÆüÄøËÝÌõ¡¢...

À®¸ùÎã
SFDA
WHO(World Health
WHO(World Health
Novartis Pharma
Beijing Municipa
Bayer
Healthcare
Chinese Medical
Nycomed Pharma
 
 
·­Òë´Ê»ãÏÂÔØ
ҽѧ´Ê»ã
¡¡¡¤ Ò©Àíѧ ¡¡¡¤ Ò©Îﻯѧ´Ê»ã ¡¡¡¤ ÐÂÒ©±¨Åú´Ê»ã
ÐÂÒ©±¨Åú´Ê»ã
English ÖÐÎÄ
acclimation
ÊÊÓ¦»·¾³
amendment approval
Åú×¼ÐÞÕý°¸
antemortem observations
ÁÙËÀÇ°¹Û²ì
Approval of study protocol
Ñо¿·½°¸Åú×¼
blank plasma
¿Õ°×Ѫ½¬
body weights
ÌåÖØ
chromatographic conditions
É«Æ×Ìõ¼þ
column
É«Æ×Öù
column temperature
ÖùÎÂ
contaminants
ÎÛȾÎï
Covance Study No.
Covance Ñо¿ºÅ
dose administration
¸øÒ©
dose analysis results
¸øÒ©·ÖÎö½á¹û
dose level
¼ÁÁ¿Ë®Æ½
dose preparation
¸øÒ©×¼±¸
dose route
¸øҩ;¾¶
drug metabolism
Ò©Îï´úл
electrospray positive
µçÅçÉäÑôÐÔ
extraction
ÌáÈ¡
extraction procedure
ÌáÈ¡³ÌÐò
final report
×ܽᱨ¸æ
final solution concentration
×îÖÕÈÜҺŨ¶È
final total volume
×îÖÕ×ÜÌå»ý
gradient
ÌݶÈ
gross necropsy
ÈâÑÛʬ¼ì
histopathology
×éÖ¯²¡Àíѧ
housing
ËÇÑø
husbandry
¹ÜÀí
Identification
¼ø±ð
injection volume
×¢ÉäÌå»ý
instrumentation
ÒÇÆ÷ʹÓÃ
internal standard
ÄÚ²¿±ê×¼
justification
Ñ¡ÔñµÄÀíÓÉ
materials and methods
²ÄÁÏÓë·½·¨
matrix
»ùÖÊ
method summary
·½·¨×ܽá
mobile phrase
Á÷¶¯Ïà
number and sex
ÊýÁ¿ÓëÐÔ±ð
number of animals
¶¯Îï±àºÅ
Objective
Ä¿µÄ
organ weights
ÔàÆ÷ÖØÁ¿
parameters
²ÎÁ¿
Pharma Inc.
Ò©Òµ¹«Ë¾
pharmacokinetic analysis
Ò©´ú¶¯Á¦Ñ§·ÖÎö
plasma analysis
Ѫ½¬·ÖÎö
polarity
¼«ÐÔ
Protocol
·½°¸
protocol date
·½°¸ÈÕÆÚ
Quality assurance
ÖÊÁ¿±£Ö¤
rat plasma
´óÊóѪ½¬
regression
»Ø¹é
run time
ÔËÐÐʱ¼ä
safety precautions
°²È«ÐÔÔ¤·À´ëÊ©
sample collection
ÑùÆ·²É¼¯
sample handling, storage and shipment
ÑùÆ·´¦Àí¡¢±£´æºÍÔËÊä
sample shipment
ÔËÊäÑùÆ·
sponsor
Ö÷°ì·½
Sponsor
Ö÷°ì·½
strain and source
ƷϵÓëÀ´Ô´
Study dates
Ñо¿ÈÕÆÚ
study monitor
Ñо¿¼à²é
study title
Ñо¿ÌâÄ¿
subcutaneous injection
ƤÏÂ×¢Éä
test article
¹©ÊÔÆ·
working stock
¹¤×÷´¢´æÒº
 
©

2004-2019Ë̵þ°ÉÎÓ°åÌôËÝÌõ¥»¥ó¥¿¡¼